cover
Contact Name
Viskasari P. Kalanjati
Contact Email
fmi@journal.unair.ac.id
Phone
-
Journal Mail Official
fmi@journal.unair.ac.id
Editorial Address
Folia Medica Indonesiana The Unit of Journal Consortium and Folia Medica Indonesiana Faculty of Medicine, Universitas Airlangga Jl. Prof. Dr. Moestopo No.47, Pacar Kembang, Kec. Tambaksari, Surabaya, Jawa Timur 60132, Indonesia
Location
Kota surabaya,
Jawa timur
INDONESIA
Folia Medica Indonesiana
Published by Universitas Airlangga
ISSN : 23558398     EISSN : 2599056X     DOI : https://doi.org/10.65346/2958-4515.2401
Core Subject : Health, Science,
Folia Medica Indonesiana, as indicated by its name, focuses on publishing good quality articles about research and education on health science and medicine in Indonesia. However, due to the fast growth of science and knowledge in these fields, we also welcome submitted articles from around the world, especially the ones that contain related matters from lower-middle income countries. Folia Medica Indonesiana is an open-access, peer-reviewed journal that is published online at least four times a year. The scope covers various aspects of basic medical sciences includes anatomy, physiology, pathology, microbiology, pharmacology, and molecular medicine) and clinical medicine (covers specialties like internal medicine, surgery, pediatrics, oncology, psychiatry, etc). We highlight the pathology and potential treatment of metabolic syndromes and infectious diseases. Folia Medica Indonesiana also encourages the publication of articles about health education. The scope includes, but is not limited to, articles that emphasize on preventive education on certain diseases in a community, also research report of various materials and/or methods to develop medical education. We recognize the importance of this type of articles to be published alongside the assigned topic in each of our yearly issues, to provide our readers with updated information in medical sciences’ research and education simultaneously.
Articles 13 Documents
Search results for , issue "Vol. 52, No. 1" : 13 Documents clear
Effect of body mass index (bmi) on mortality and readmission of heart failure patients in cardiovascular outpatient care unit at dr. Soetomo hospital, surabaya Lestari, Sella Rizkita; Andrianto, Andrianto; Nugroho, J
Folia Medica Indonesiana Vol. 52, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Obesity is one of risk factors for heart failure in both men and women. Paradoxically, recent studies have shown that high BMIs in heart failure patients were asssociated with better outcomes. This study was aimed to prove the effect of body mass index on mortality and readmission in heart failure patients in cardiovascular outpatient care unit at Dr. Soetomo Surabaya Hospital. The research design was observational analytical study. Subjects consisted of all patients with heart disease in cardiovascular outpatient care unit at Dr. Soetomo Surabaya Hospital that meet the inclusion and exclusion criteria. Through the purposive sampling, 59 patients diagnosed with heart failure were selected. Direct measurements of body weight and height were conducted in February through March 2014 to calculate the BMIs. Based on their BMIs, subjects were then placed into two categories, which were patients with normal and elevated BMIs. Information on deaths and readmissions were gathered in October 2014. The relationship between two variables were then analyzed using Fisher Exact Test. After 8 months of follow up, 5 people (8.5%) died of cardiovascular cause and 7 (11.9%) were re-admitted to the hospital. Among 28 patients with normal BMIs, 3 (10.7%) died and 3 (10.7%) were re-admitted. Among 31 patients with elevated BMIs, 2 (6.5%) died and 4 (12.9%) were re-admitted to the hospital. By using Fisher Exact Test, it was shown that there is no effect of BMI on mortality (p=0.661) and readmission (p=1.000) in heart failure patients.
Case report: secondary laparoscopic assissted transanal endorectal pull-through. A pre-eliminary study Barmadisatrio, Barmadisatrio; Hariono, Hariono
Folia Medica Indonesiana Vol. 52, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The definitive treatment for Hirschsprung's disease is pullthrough procedure, that can be done through conventional pullthrough approach or through minimal invasive approach. The benefit of minimal invasive technique compared to conventinal open procedure is shorter time to oral intake, shorter length of stay, and less postoperative pain. Secondary LATEP is a minimal invasive pull through technique in patients with preexisting colostomy. Primary pullthrough sometimes cannot be done because limitation of health facilities, uneven distribution of pediatric surgeons throughout the country and late diagnosis of Hirschsprung's Disease. In dr Soetomo Hospital Surabaya, 7 secondary LATEP procedures were done in January to August 2014. The age range was 6 months to 8 years old. All patients survived, 1 patient had stenosis of anastomotic site 2 weeks postoperative, 3 had enterocolitis, 3 with no complication. Secondary LATEP is a minimal invasive approach for Hirschsprung's Disease that can be adjusted with Indonesia's social and economic condition, where most population was distant from an adequate health facility. As there is high incidence of malnutrition, enterocolitis and also the distance from appropriate health services, stoma formation is the first thing that can be done before definitive treatment.Secondary LATEP has never been done in Indonesia, and we still need more data and research to evaluate the benefit and disadvantage of this approach compared to conventional or minimal invasive primary pull through. In conclusion, secondary LATEP is an appropriate pullthrough alternative for Hirschsprung's Disease and applicable in Indonesia, considering the social and economy condition. Further study must be done to develop this method.
Effects of edamame (glycine max) extracton post-prandial serum triglyceride in wistar rats Kamal, Imran H; Dewanti, Linda; Wironegoro, Rio
Folia Medica Indonesiana Vol. 52, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Edamame (Glycine max) is a preparation of immature soybeans in the pod, which is high in calcium and dietary fiber, two elements described in previous studies that could alter the level of post-prandial serum triglyceride.The purpose of this research is to analyze the effect of edamame (Glycine max) extract on post-prandial serum triglyceride in rats after intragastric administration of palm oil.The materials used in this study are palm oil, edamame extract, and ether. The design of this study is experimental post-test study design, which is a design to measure the serum triglyceride level after meal with and without Glycine max. Triglyceride is measured on each subject two times on total, first one after consumption of meal without Glycine max and the second one after consumption of meal with Glycine max. There is a washout period of 1 week between two times the samples were taken. Both results are then compared in every subject.The level of 2-hour post-prandial serum triglyceride in rats after palm oil without intragastric edamame (Glycine max) extract administration and with intragastric edamame (Glycine max) extract administration showed no significant difference. In conclusion, edamame (Glycine max) extract had no effect on 2-hour post-prandial serum triglyceride after palm oil administration via intragastric tube.

Page 2 of 2 | Total Record : 13